We recently compiled a list of 11 Best Future Stocks to Buy Now. Vaxcyte, Inc. stands second on our list among the best future stocks. Vaxcyte, Inc. (NASDAQ:PCVX) is a clinical-stage biotech company ...
Final VAX-24 Infant Phase 2 Dose-Finding Study Data Consistent with Previously Reported Positive Interim Data: In March 2025, the Company announced topline, interim data from the VAX-24 infant Phase 2 ...
Anti-VEGF use for ROP is expanding beyond bevacizumab and ranibizumab, with aflibercept’s fusion-protein structure conferring systemic exposure characteristics distinct from antibody-based agents.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results